Formestane

From Wikipedia, the free encyclopedia

Formestane
Systematic (IUPAC) name
(8R,9S,10R,13S,14S)-4-hydroxy-10,13-dimethyl-
2,6,7,8,9,11,12,14,15,16-decahydro-1H-
cyclopenta[a]phenanthrene-3,17-dione
Identifiers
CAS number 566-48-3
ATC code L02BG02
PubChem 11273
Chemical data
Formula C19H26O3 
Mol. mass 302.408 g/mol
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?

Legal status
Routes  ?

Formestane belongs to a class of drugs known as aromatase inhibitors. It is used in the treatment of estrogen-receptor positive breast cancer in post-menopausal women. It is available as an intramuscular depot injection (Lentaron).

Formestane is often used to suppress estrogen production from anabolic steroids or prohormones. It also acts as a prohormone to 4-hydroxytestosterone, an active steroid which displays weak androgenic activity in addition to acting as a mild aromatase inhibitor.

Formestane has poor oral bioavailability and as such is no longer popular as many orally available aromatase inhibitors have been developed.